Upload Avatar (500 x 500)
Wei-Qiang Tan
nxwrtbn@163.com
Chinese, English
Fujian
Xiamen University
Medical
  • 1998-2003 Bachelor of Medicine: Fudan University
  • 2003-2006 Master of Medicine in Pediatrics: Fudan University
  • 2008-2013 Doctor of Medicine in Pediatrics: Fudan University
  • 2006.07-2020.05 - Fudan University Children's Hospital - Resident Doctor, Attending Doctor, Associate Chief Physician
  • 2020.08-present - Xiamen University Xiang'an Hospital - Associate Chief Physician
  • 2022.10-present - Xiamen University School of Medicine - Associate Professor
Organ Transplantation (Kidney Transplantation)
Pediatric Cardiac Surgery
  • Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma., Wei-Qiang Tan, Li Yuan, Xiao-Yan Wu, and Ming Ye, 2022
  • Overexpression of IncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo., Wei-Qiang Tan, Li Yuan, Xiao-Yan Wu, and Ming Ye, 2022
  • Artemisinin inhibits neuroblastoma proliferation through activation of AHP-activated protein kinase (AMPK) signaling., Wei-qiang Tan, Gang Chen, Bing Jia, Ming Ye, 2014
  • Artemether Regulates Chemosensitivity to Doxorubicin via Regulation of B7-H3 in Human Neuroblastoma Cells., Wei-qiang Tan, Gang Chen, Bing Jia, Ming Ye, 2017
  • Long non-coding RNA CRNDE functions as a tumor promoter by modulating ERK/MAPK signaling pathway in neuroblastoma cells., Ann Clin Lab, 2022
  • TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma., Gang Chen, Weicheng Chen, Ming Ye, Weiqiang Tan and Bing Jia, 2019
  • Relationship between a Tracheal and Left Pulmonary Artery Stenosis Index and the Prognosis of Pulmonary Artery Sling with Tracheal Stenosis., Xiao Shen, WeiQiang Tan, Bing Jia, Ming Ye, 2021
Kidney Transplantation Organ Transplantation Pediatric Surgery Cardiac Surgery Congenital Heart Disease Postoperative Care Icu Chemoresistance Neuroblastoma Immunotherapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.